Welcome to
Издательство Атмосфера

· Журналы
· Книги
· О проекте

·Электронные версии книг издательства “Атмосфера” поступили в продажу

Издательство “Атмосфера” идет в ногу со временем и открывает на своем сайте раздел электронных версий своих книг. Теперь вы можете приобрести не только традиционную бумажную книгу в картонном переплете, но и .pdf-файл, снабженный гиперссылками на каждую главу издания. В электронной версии проще отыскать рисунок и таблицу. Чтобы обратиться к ним, достаточно нажать на ссылку на каждый из них. Исчезла зависимость от тиража – вы можете приобрести даже те бестселлеры, тираж которых уже разошелся, такие как “Саркоидоз” или “Заболевания органов дыхания при беременности”. Упростилось получение вами книг – в течение двух рабочих дней после оплаты требуемые файлы придут на ваш e-mail. Ну и наконец, цена – электронные версии наших книг гораздо дешевле, чем бумажные издания. Заказывайте электронные версии книг издательства “Атмосфера” на сайте, а также по телефону: (495) 730-63-51 и по e-mail: atm-press2012@yandex.ru



ИНТЕРНЕТ-МАГАЗИН
Издательство Атмосфера


Телефон издательства

  
Нервные болезни
2021 / N 1

Гиперинтенсивность белого вещества в диагностике мигрени
Л.А. Добрынина, А.Д. Суслина, М.В. Губанова, А.В. Белопасова, А.Н. Сергеева, М.В. Кротенкова

References

1. Lipton RB, Bigal ME, Diamond M, Freitag F, Reed L, Stewart WF; AMPP Advisory Group. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology 2007 Jan;68(5):343-9.
2. Global Burden of Disease Study 2013 Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. The Lancet 2015 Aug;386(9995):743-800.
3. Headache Classification Committee of the International Headache Society (IHS). The International classification of headache disorders, 3rd edition. Cephalalgia 2018 Jan;38(1):1-211.
4. Kruit MC, van Buchem MA, Launer LJ, Terwindt GM, Ferrary MD. Migraine is associated with an increased risk of deep white matter lesions, subclinical posterior circulation infarcts and brain iron accumulation: the population-based MRI CAMERA study. Cephalalgia 2010 Feb;30(2):129-36.
5. Dinia L, Bonzano L, Albano В, Finocchi C, Del Sette M, Saitta L, Castellan L, Gandolfo C, Roccatagliata L. White matter lesions progression in migraine with aura: a clinical and MRI longitudinal study. Journal of Neuroimaging 2013 Jan;23(1):47-52.
6. Uggetti C, Squarza S, Longaretti F, Galli A, Di Fiore P, Reganati PF, Campi A, Ardemagni A, Cariati M, Frediani F. Migraine with aura and white matter lesions: an MRI study. Neurological Sciences 2017 May;38( Suppl 1):11-3.
7. Kruit MC, van Buchem MA, Hofman PA, Bakkers JTN, Terwindt GM, Ferrari MD, Launer LJ. Migraine as a risk factor for subclinical brain lesions. JAMA 2004 Jan;291(4):427-34.
8. Kamson DO, Illés Z, Aradi M, Orsi G, Perlaki G, Leél-Őssy E, Erdélyi-Botor S, Pótó L, Trauninger A, Pfund Z. Volumetric comparisons of supratentorial white matter hyperintensities on FLAIR MRI in patients with migraine and multiple sclerosis. Journal of Clinical Neuroscience 2012 May;19(5):696-701.
9. Hougaard A, Amin FM, Ashina M. Migraine and structural abnormalities in the brain. Current Opinion in Neurology 2014 Jun;27(3):309-14.
10. Russo A, Silvestro M, Tessitore A, Tedeschi G. Advances in migraine neuroimaging and clinical utility: from the MRI to the bedside. Expert Review of Neurotherapeutics 2018 Jul;18(7):533-44.
11. Scher AI, Gudmundsson LS, Sigurdsson S, Ghambaryan A, Aspelund T, Eiriksdottir G, van Buchem MA, Gudnason V, Launer LJ. Migraine headache in middle age and late-life brain infarcts. JAMA 2009 Jun;301(24):2563-70.
12. Kurth T, Mohamed S, Maillard P, Zhu YC, Chabriat H, Mazoyer B, Bousser MG, Dufouil C, Tzourio C. Headache, migraine, and structural brain lesions and function: population based Epidemiology of Vascular Ageing-MRI study. BMJ 2011 Jan;342:c7357.
13. Palm-Meinders IH, Koppen H, Terwindt GM, Launer LJ, Konishi J, Moonen JME, Bakkers JT, Hofman PA, van Lew B, Middelkoop H, van Buchem MA, Ferrari MD, Kruit MC. Structural brain changes in migraine. JAMA 2012 Nov;308(18):1889-97.
14. Hamedani AG, Rose KM, Peterlin BL, Mosley TH, Coker LH, Jack CR, Knopman DS, Alonso A, Gottesman RF. Migraine and white matter hyperintensities: the ARIC MRI study. Neurology 2013 Oct;81(15):1308-13.
15. Bashir A, Lipton RB, Ashina S, Ashina M. Migraine and structural changes in the brain: a systematic review and meta-analysis. Neurology 2013 Oct;81(14):1260-8.
16. Monteith T, Gardener H, Rundek T, Dong C, Yoshita M, Elkind M, DeCarli C, Sacco RL, Wright CB. Migraine, white matter hyperintensities, and subclinical brain infarction in a diverse community: the northern Manhattan study. Stroke 2014 Jun;45(6):1830-2.
17. Zheng Z, Xiao Z, Shi X, Ding M, Di W, Qi W, Zhang A, Fang Y. White matter lesions in chronic migraine with medication overuse headache: a cross-sectional MRI study. Journal of Neurology 2014 Apr;261(4):784-90.
18. Koreshkina MI, Osipova VV, Khalikov AD, Nazinkina YuV, Trofimova TN. Significance of MRI in migraine diagnostic algorithm, changes detected. Ural Medical Journal 2013;1(106):25-32 (In Russian).
19. Trauninger A, Leél-Őssy E, Kamson DO, Pótó L, Aradi M, Kövér F, Imre M, Komáromy H, Erdélyi-Botor S, Patzkó Á, Pfund Z. Risk factors of migraine-related brain white matter hyperintensities: an investigation of 186 patients. The Journal of Headache and Pain 2011 Feb;12(1):97-103.
20. Toghae M, Rahimian E, Abdollahi M, Shoar S, Naderan M. The prevalence of magnetic resonance imaging hyperintensity in migraine patients and its association with migraine headache characteristics and cardiovascular risk factors. Oman Medical Journal 2015 May;30(3):203-7.
21. Spector JT, Kahn SR, Jones MR, Jayakumar M, Dalal D, Nazarian S. Migraine headache and ischemic stroke risk: an updated meta-analysis. The American Journal of Medicine 2010 Jul;123(7):612-24.
22. Wang J, Xu W, Sun S, Yu S, Fan Li. Headache disorder and the risk of dementia: a systematic review and meta-analysis of cohort studies. The Journal of Headache and Pain 2018 Oct;19(1):95.
23. Gaist D, Garde E, Blaabjerg M, Nielsen HH, Krøigård Th, Østergaard K, Møller HS, Hjelmborg J, Madsen CG, Iversen P, Kyvik KO, Siebner HR, Ashinaet M. Migraine with aura and risk of silent brain infarcts and white matter hyperintensities: an MRI study. Brain 2016 Jul;139(Pt 7):2015-23.
24. Xie H, Zhang Q, Huo K, Liu R, Jian ZJ, Bian YT, Li GL, Zhu D, Zhang LH, Yang J, Luo GG. Association of white matter hyperintensities with migraine features and prognosis. BMC Neurology 2018 Jul;18(1):93.
25. Hu F, Qian ZW. Characteristic analysis of white matter lesions in migraine patients with MRI. European Review for Medical and Pharmacological Sciences 2016;20(6):1032-6.
26. Rościszewska-Żukowska I, Zając-Mnich M, Janik P. Characteristics and clinical correlates of white matter changes in brain magnetic resonance of migraine females. Neurologia i Neurochirurgia Polska 2018 Nov-Dec;52(6):695-703.
27. Honningsvåg LM, Håberg AK, Hagen K, Kvistad KA, Stovner LJ, Linde M. White matter hyperintensities and headache: a population-based imaging study (HUNT MRI). Cephalalgia 2018 Nov;38(13):1927-39.
28. Erdélyi-Bótor S, Aradi M, Kamson DO, Kovács N, Perlaki G, Orsi G, Nagy SA, Schwarcz A, Dóczi T, Komoly S, Deli G, Trauninger A, Pfund Z. Changes of migraine-related white matter hyperintensities after 3 years: a longitudinal MRI study. Headache 2015 Jan;55(1):55-70.
29. Dobrynina LA, Gnedovskaya EV, Sergeyeva AN, Krotenkova MV, Piradov MA. Changes in MRI brain picture associated with newly diagnosed asymptomatic arterial hypertension. Annals of Clinical and Experimental Neurology 2016;10(3):25-32 (In Russsian).
30. Dobrynina LA, Gnedovskaya EV, Sergeyeva AN, Krotenkova MV, Piradov MA. Subclinical cerebral manifestations and brain damage associated with newly diagnosed asymptomatic arterial hypertension. Annals of Clinical and Experimental Neurology 2016;10(3):33-9 (In Russian).
31. Martorell MS, Blázquez MC, Figueredo GD, Ortiz GS, Front CJ. Hyperintense punctiform images in the white matter: a diagnostic approach. Radiologia 2012 Jul-Aug;54(4):321-35.
32. Kanekar S, Devgun P. A pattern approach to focal white matter hyperintensities on magnetic resonance imaging. Radiologic Clinics of North America 2014 Mar;52(2):241-61.
33. Task Force Members; Montalescot G, Sechtem U, Achenbach S, Andreotti F, Arden C, Budaj A, Bugiardini R, Crea F, Cuisset T, Di Mario C, Ferreira JR, Gersh BJ, Gitt AK, Hulot JS, Marx N, Opie LH, Pfisterer M, Prescott E, Ruschitzka F, Sabaté M, Senior R, Taggart DP, van der Wall EE, Vrints CJM; ESC Committee for Practice Guidelines; Zamorano JL, Achenbach S, Baumgartner H, Bax JJ, Bueno H, Dean V, Deaton C, Erol C, Fagard R, Ferrari R, Hasdai D, Hoes AW, Kirchhof P, Knuuti J, Kolh P, Lancellotti P, Linhart A, Nihoyannopoulos P, Piepoli MF, Ponikowski P, Sirnes PA, Tamargo JL, Tendera M, Torbicki A, Wijns W, Windecker S; Document Reviewers; Knuuti J, Valgimigli M, Bueno H, Claeys MJ, Donner-Banzhoff N, Erol C, Frank H, Funck-Brentano C, Gaemperli O, Gonzalez-Juanatey JR, Hamilos M, Hasdai D, Husted S, James SK, Kervinen K, Kolh P, Kristensen SD, Lancellotti P, Maggioni AP, Piepoli MF, Pries AR, Romeo F, Rydén L, Simoons ML, Sirnes PA, Steg PG, Timmis A, Wijns W, Windecker S, Yildirir A, Zamorano JL. 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. European Heart Journal 2013 Oct;34(38):2949-3003.
34. Wardlaw JM, Smith EE, Biessels GJ, Cordonnier Ch, Fazekas F, Frayne R, Lindley RI, O’Brien JT, Barkhof F, Benavente OR, Black SE, Brayne C, Breteler M, Chabriat H, DeCarli C, de Leeuw FE, Doubal F, Duering M, Fox NC, Greenberg S, Hachinski V, Kilimann I, Mok V, van Oostenbrugge R, Pantoni L, Speck O, Stephan BCM, Teipel S, Viswanathan A, Werring D, Chen C, Smith C, van Buchem M, Norrving B, Gorelick PB, Dichgans M; STandards for ReportIng Vascular changes on nEuroimaging (STRIVE v1). Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. The Lancet. Neurology 2013 Aug;12(8):822-38.
35. Kim KW, MacFall JR, Payne ME. Classification of white matter lesions on magnetic resonance imaging in elderly persons. Biological Psychiatry 2008 Aug;64(4):273-80.
36. Pantoni L. Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. The Lancet. Neurology 2010 Jul;9(7):689-701.
37. Debette S, Markus HS. The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ 2010 Jul;341:c3666.
38. Habes M, Erus G, Toledo JB, Zhang T, Bryan N, Launer LJ, Rosseel Y, Janowitz D, Doshi J, Van der Auwera S, von Sarnowski B, Hegenscheid K, Hosten N, Homuth G, Volzke H, Schminke U, Hoffman W, Grabe HJ, Davatzikos C. White matter hyperintensities and imaging patterns of brain ageing in the general population. Brain 2016 Apr;139(Pt 4):1164-79.
39. Kruit MC, Launer LJ, Ferrari MD, van Buchem MA. Infarcts in the posterior circulation territory in migraine. The population-based MRI CAMERA study. Brain 2005 Sep;128(Pt 9):2068-77.
40. Freeze WM, Jacobs HIL, Schreuder FHBM, van Oostenbrugge RJ, Backes WH, Verhey FR, Klijn CJM. Blood-brain barrier dysfunction in small vessel disease related intracerebral hemorrhage. Frontiers in Neurology 2018 Nov;9:926.
41. Boulouis G, de Boysson H, Zuber M, Guillevin L, Meary E, Costalat V, Pagnoux C, Naggara O. Primary angiitis of the central nervous system: magnetic resonance imaging spectrum of parenchymal, meningeal, and vascular lesions at baseline. Stroke 2017 May;48(5):1248-55.
42. Byram K, Hajj-Ali RA, Calabrese L. CNS vasculitis: an аpproach to differential diagnosis and management. Current Rheumatology Reports 2018 May;20(7):37.
43. Dodick DW. A phase-by-phase review of migraine pathophysiology. Headache 2018 May;58(Suppl 1):4-16.
44. Akerman S, Holland PR, Goadsby PJ. Diencephalic and brainstem mechanisms in migraine. Nature Reviews. Neuroscience 2011 Sep;12(10):570-84.
45. Bernstein C, Burstein R. Sensitization of the trigeminovascular pathway: perspective and implications to migraine pathophysiology. Journal of Clinical Neurology (Seoul, Korea) 2012;8(2):89-99.
46. Low A, Mak E, Rowe JB, Markus HS, O’Brien JT. Inflammation and cerebral small vessel disease: a systematic review. Ageing Research Review 2019 Aug;53:100916.
47. Wardlaw JM, Smith C, Dichgans M. Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging. The Lancet. Neurology 2013 May;12(5):483-97.
48. Bussolati B, Dunk C, Grohman M, Kontos CD, Mason J, Ahmed A. Vascular endothelial growth factor receptor-1 modulates vascular endothelial growth factor-mediated angiogenesis via nitric oxide. The American Journal of Pathology 2001 Sep;159(3):993-1008.
49. Rodríguez-Osorio X, Sobrino T, Brea D, Martínez F, Castillo J, Leira R. Endothelial progenitor cells: a new key for endothelial dysfunction in migraine. Neurology 2012 Jul;79(5):474-9.
50. Michalak S, Kalinowska-Lyszczarz A, Wegrzyn D, Thielemann A, Osztynowicz K, Kozubski W. The levels of circulating proangiogenic factors in migraineurs. Neuromolecular Medicine 2017 Dec;19(4):510-7.
51. Gonçalves FM, Martins-Oliveira A, Speciali JG, Izidoro-Toledo TC, Luizon MR, Dach F, Tanus-Santos JE. Vascular endothelial growth factor genetic polymorphisms and haplotypes in women with migraine. DNA and Cell Biology 2010 Jul;29(7):357-62.
  

[ Содержание выпуска N 1 | Выпуски журнала | Список журналов ]